Therabron Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Out of Business

Therabron Therapeutics General Information

Description

Developer of novel drugs with therapeutic proteins designed to cure respiratory diseases. The company's novel drugs with therapeutic proteins develop a series of recombinant human secretoglobins, enabling patients to access treatments for a range of orphan and more commonplace respiratory diseases impacting people from infancy through adulthood.

Contact Information

Formerly Known As
Clarassance, Clarassance, Inc.
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 9430 Key West Avenue
  • Suite 150
  • Rockville, MD 20850
  • United States
+1 (240)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 9430 Key West Avenue
  • Suite 150
  • Rockville, MD 20850
  • United States
+1 (240)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therabron Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Nov-2018 Completed Out of Business
7. Later Stage VC 27-Dec-2016 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 18-Nov-2015 Completed Generating Revenue
5. Later Stage VC 17-Jun-2014 Completed Generating Revenue
4. Grant 24-Sep-2012 Completed Startup
3. Angel (individual) 17-Sep-2012 Completed Startup
2. Angel (individual) 10-Nov-2011 $315K $315K Completed Startup
1. Grant 29-Oct-2010 $244K Completed Startup
To view Therabron Therapeutics’s complete valuation and funding history, request access »

Therabron Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A4
Series A3
Series A2 89,683 $0.001000 $6.3 $6.3 1x $6.3 2.2%
Series A1 116,279 $0.001000 $2.15 $2.15 1x $2.15 2.85%
To view Therabron Therapeutics’s complete cap table history, request access »

Therabron Therapeutics Patents

Therabron Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016205430-A1 Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke Inactive 15-Jun-2015
WO-2016133560-A1 Recombinant human cc10 protein for treatment of influenza and ebola Inactive 16-Feb-2015
US-20160159870-A1 Compositions and methods of use for recombinant human secretoglobins Active 15-Mar-2013
US-9765127-B2 Compositions and methods of use for recombinant human secretoglobins Active 15-Mar-2013
AU-2014233116-A1 Improved methods of use for recombinant human secretoglobins Inactive 15-Mar-2013 C07K14/47
To view Therabron Therapeutics’s complete patent history, request access »

Therabron Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therabron Therapeutics FAQs

  • When was Therabron Therapeutics founded?

    Therabron Therapeutics was founded in 2007.

  • Where is Therabron Therapeutics headquartered?

    Therabron Therapeutics is headquartered in Rockville, MD.

  • What is the size of Therabron Therapeutics?

    Therabron Therapeutics has 9 total employees.

  • What industry is Therabron Therapeutics in?

    Therabron Therapeutics’s primary industry is Drug Discovery.

  • Is Therabron Therapeutics a private or public company?

    Therabron Therapeutics is a Private company.

  • What is Therabron Therapeutics’s current revenue?

    The current revenue for Therabron Therapeutics is .

  • How much funding has Therabron Therapeutics raised over time?

    Therabron Therapeutics has raised $16.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process